Skip to Content
216.861.6200

St. Vincent Surgeons Participate in Nationwide Clinical Trial of 2-level Total Disc Replacement for Symptomatic Cervical Disc Disease

By Brad Hauber on 
Posted on July 23, 2020

St. Vincent Surgeons Participate in Nationwide Clinical Trial of 2-level Total Disc Replacement for Symptomatic Cervical Disc Disease

Those interested in participating in this 2-level cervical implant trial should contact Jayson Zadzilka at 330.205.1334. To schedule a consultation with Dr. McLain, please contact 440.248.1297. To schedule a consultation with Dr. Anderson, please contact 216.369.2830.

Two St. Vincent Charity Medical Center surgeons, Robert McLain M.D., and James Anderson M.D., are participating in a nationwide clinical trial investigating the safety and effectiveness of two new total disc replacement (TDR) devices (prodisc® C SK and prodisc® C Vivo) intended for the treatment of 2-level cervical disc disease.

“Cervical disc replacement implants have been proven to be a safe and effective treatment for many patients experiencing one-level disc disease, avoiding fusion and allowing for more natural neck motion compared to cervical fusion,” said Dr. McLain, the principal investigator for the study at St. Vincent Charity. “However, most products on the market do not allow for use in patients with 2-level cervical disc disease. This study will evaluate the effectiveness of these two new implants to provide relief for the millions of Americans suffering from multi-level degenerative disc disease.”

Neck pain ranks in the top 5 disorders in the United States, with 30 to 50 percent of people reporting incidents of neck pain. While the majority of acute symptoms will resolve with non-operative or conservative treatments, nearly 30 percent of those with neck pain will develop chronic symptoms.

The prodisc products being used in the trial are built on the prodisc technology platform, the most widely used total disc replacement system in the world. No other disc replacement system has been studied more, with over 13,000 patients reported on in more than 540 articles over the last 30 years. Over 125,000 prodisc devices have been implanted world-wide, with a reported reoperation rate of less than 1 percent. The prodisc C Vivo has been used outside the US for over 10 years, and the prodisc C SK device is an evolution of the original prodisc C with smaller keel design.

“Our selection as the only hospital in Cleveland and the state of Ohio to participate in this study furthers St. Vincent Charity’s Spine and Orthopedic Institute’s reputation as a leader in health care excellence and cutting edge sophistication,” Dr. Anderson said. The study currently includes 21 sites in 15 states across the country with an expected primary completion date of Spring 2023.

Approximately 20 patients will be included in the study at St. Vincent. Patients between 18 and 69 years of age, suffering from neck and arm pain due to cervical disc disease who have not responded to non-operative treatment will be considered for the study. Those interested in participating, should contact Jayson Zadzilka (330.205.1334 or jzbiomedical@gmail.com). For more information about this study, visit clinicaltrials.gov (Identifier NCT04012996).


Those interested in participating in this 2-level cervical implant trial should contact Jayson Zadzilka at 330.205.1334. To schedule a consultation with Dr. McLain, please contact 440.248.1297. To schedule a consultation with Dr. Anderson, please contact 216.369.2830.

Those interested in participating in this 2-level cervical implant trial should contact Jayson Zadzilka at 330.205.1334. To schedule a consultation with Dr. McLain, please contact 440.248.1297. To schedule a consultation with Dr. Anderson, please contact 216.369.2830.

Tags:


Categories:


Recent posts

Rosary Hall's outpatient director speaks to Cleveland Jewish News about rise in telehealth

Rosary Hall's outpatient director speaks to Cleveland Jewish News about rise in telehealth

Telehealth has been around for years, but it was not until the COVID-19 pandemic that its availability and use really grew. Telehealth services reduce barriers to treatment by allowing patients to see providers remotely for certain conditions. Russell Spieth, Ph.D., director of outpatient services at St. Vincent Charity Medical Center’s Rosary Hall, spoke to Cleveland Jewish News about the increase in telehealth services and the impact it could have on health outcomes.
Read More
Resolve to lose weight to reduce arthritis pain

Resolve to lose weight to reduce arthritis pain

Maintaining a healthy body weight is important for overall health. Most Americans know it’s importance in reducing risks of heart disease, diabetes and cancer. However, many may be surprised to learn excess weight not only exacerbates pain from arthritis, but significantly increases the risk of a patient developing arthritis in the first place.
Read More
A thank you to the community for helping slow the spread of COVID-19

A thank you to the community for helping slow the spread of COVID-19

We’ve made it to this point together. And that is exactly the reason for this message. We start with pride for our caregiving teams who make patient care their top priority. Our gratitude goes to caregivers at the bedside and those behind the scenes who make our health systems succeed every day of every year.
Read More